| 1 | 4420248 | [Determination of phenol in the coastal sea organisms of the Kvarner bay and island of Visa]. | Arh Hig Rada Toksikol | 1974 |
1 |
| 2 | 9272582 | Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. | MMWR Morb Mortal Wkly Rep | 1997 Aug 22 |
2 |
| 3 | 9310213 | Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. | MMWR Morb Mortal Wkly Rep | 1997 Sep 5 |
1 |
| 4 | 10348061 | The threat of vancomycin resistance. | Am J Med | 1999 May 3 |
2 |
| 5 | 10585815 | Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci. | Clin Infect Dis | 1999 Dec |
2 |
| 6 | 11679564 | The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model. | J Antimicrob Chemother | 2001 Nov |
8 |
| 7 | 11758077 | Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. | Med J Aust | 2001 Nov 5 |
3 |
| 8 | 12461035 | The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland. | J Antimicrob Chemother | 2002 Dec |
1 |
| 9 | 14727222 | Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. | Clin Infect Dis | 2004 Feb 1 |
2 |
| 10 | 15310263 | Emergence of heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) infection in Western Australia. | Med J Aust | 2004 Aug 16 |
1 |
| 11 | 15561884 | Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. | Antimicrob Agents Chemother | 2004 Dec |
2 |
| 12 | 15700681 | [Is the methicillin-resistant Staphylococcus aureus heteroresistant to vancomycin in Croatia?]. | Acta Med Croatica | 2004 |
4 |
| 13 | 15780422 | Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin. | J Infect | 2005 Apr |
3 |
| 14 | 15889359 | Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area. | Clin Infect Dis | 2005 Jun 1 |
3 |
| 15 | 16271057 | Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA). | Intern Med J | 2005 Dec |
3 |
| 16 | 16301520 | Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. | Proc Natl Acad Sci U S A | 2005 Dec 6 |
5 |
| 17 | 16801409 | Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. | Antimicrob Agents Chemother | 2006 Jul |
4 |
| 18 | 16856450 | The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand. | J Med Assoc Thai | 2005 Nov |
3 |
| 19 | 16940100 | Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. | Antimicrob Agents Chemother | 2006 Sep |
6 |
| 20 | 17121303 | Detection of heterogeneous, intermediate-vancomycin-resistant Staphylococcus aureus (hVISA) using low-concentration vancomycin disks. | Southeast Asian J Trop Med Public Health | 2006 Jul |
4 |
| 21 | 17344363 | Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center. | J Clin Microbiol | 2007 May |
1 |
| 22 | 17392790 | TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. | Nature | 2007 Apr 19 |
1 |
| 23 | 17531446 | Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). | Int J Antimicrob Agents | 2007 Aug |
3 |
| 24 | 17888634 | Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). | Int J Antimicrob Agents | 2007 Nov |
7 |
| 25 | 18159402 | VISA, hetero-VISA and VRSA: the end of the vancomycin era? | Can J Infect Dis | 2002 Sep |
1 |
| 26 | 18207245 | Identification of MAVS splicing variants that interfere with RIGI/MAVS pathway signaling. | Mol Immunol | 2008 Apr |
1 |
| 27 | 18304359 | Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. | BMC Microbiol | 2008 Feb 27 |
5 |
| 28 | 18632899 | Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). | J Clin Microbiol | 2008 Sep |
4 |
| 29 | 18984644 | Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations. | J Antimicrob Chemother | 2009 Jan |
6 |
| 30 | 19015334 | Impact of inoculum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in vitro pharmacodynamic model. | Antimicrob Agents Chemother | 2009 Feb |
5 |
| 31 | 19028632 | First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary. | J Chemother | 2008 Oct |
1 |
| 32 | 19043919 | Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection. | Antivir Ther | 2008 |
3 |
| 33 | 19136530 | Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides. | J Antimicrob Chemother | 2009 Mar |
5 |
| 34 | 19155225 | Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model. | J Antimicrob Chemother | 2009 Apr |
1 |
| 35 | 19199552 | Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. | J Infect Dis | 2009 Mar 1 |
3 |
| 36 | 19275538 | Discovery of medically significant lantibiotics. | Curr Drug Discov Technol | 2009 Mar |
2 |
| 37 | 19369444 | Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years. | J Clin Microbiol | 2009 Jun |
3 |
| 38 | 19380491 | Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter. | Mol Cell Biol | 2009 Jun |
1 |
| 39 | 19387707 | Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore. | Eur J Clin Microbiol Infect Dis | 2009 Aug |
4 |
| 40 | 19451283 | Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem. | Antimicrob Agents Chemother | 2009 Aug |
8 |
| 41 | 19506056 | Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. | Antimicrob Agents Chemother | 2009 Aug |
5 |
| 42 | 19546225 | Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS. | J Biol Chem | 2009 Aug 14 |
1 |
| 43 | 19546358 | Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China. | Antimicrob Agents Chemother | 2009 Sep |
3 |
| 44 | 19561147 | A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. | J Antimicrob Chemother | 2009 Sep |
2 |
| 45 | 19576240 | Atlantic salmon IPS-1 mediates induction of IFNa1 and activation of NF-kappaB and localizes to mitochondria. | Dev Comp Immunol | 2009 Nov |
1 |
| 46 | 19635904 | Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways. | J Immunol | 2009 Aug 15 |
4 |
| 47 | 19669308 | Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers. | Hepatol Int | 2008 Jun |
1 |
| 48 | 19732456 | Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients. | BMC Microbiol | 2009 Sep 4 |
1 |
| 49 | 19738009 | In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollow fiber model. | Antimicrob Agents Chemother | 2009 Nov |
1 |
| 50 | 19740998 | Cleavage of IPS-1 in cells infected with human rhinovirus. | J Virol | 2009 Nov |
1 |